Skip to main content
Top

Clinical and Translational Oncology

Issue 12/2013

Content (11 Articles)

Editorial

SEOM Guidelines 2013: a response to the needs of Spanish oncologists

J. J. Cruz-Hernández, C. A. Rodríguez

Clinical Guides in Oncology

SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2013

C. Camps, E. Felip, R. García-Campelo, J. M. Trigo, P. Garrido

Clinical Guides in Oncology

SEOM clinical guidelines for the treatment of small-cell lung cancer 2013

M. Dómine Gómez, T. Morán Bueno, A. Artal Cortés, J. Remon Masip, P. Lianes Barragán

Clinical Guides in Oncology

SEOM clinical guidelines for the adjuvant treatment of colorectal cancer 2013

J. Maurel, C. Grávalos, F. Rivera, R. Vera, E. González Flores

Clinical Guides in Oncology

SEOM Clinical guidelines for the treatment of advanced colorectal cancer 2013

E. Casado-Saenz, J. Feliu, M. A. Gomez-España, A. Sanchez-Gastaldo, R. Garcia-Carbonero

Clinical Guides in Oncology

SEOM clinical guidelines for the management of metastatic breast cancer 2013

A. Llombart Cussac, J. de la Haba Rodríguez, A. Ruiz Simón, I. Álvarez López, J. Cortés Castán

Clinical Guides in Oncology

SEOM Clinical Guidelines for the systemic treatment of early breast cancer 2013

S. Del Barco, E. Ciruelos, I. Tusquets, M. Ruiz, A. Barnadas

Clinical Guides in Oncology

SEOM clinical guidelines for the treatment of head and neck cancer (HNC) 2013

R. Mesía, M. Pastor, J. J. Grau, E. del Barco

Clinical Guides in Oncology

SEOM clinical guidelines for the treatment of nasopharyngeal carcinoma 2013

R. Mesía, M. Pastor, J. J. Grau, E. del Barco

Clinical Guides in Oncology

SEOM guide to antiemetic prophylaxis in cancer patients treated with chemotherapy 2013

J. García Gómez, M. E. Pérez López, M. Alonso Bermejo, Y. Escobar Álvarez, J. García Mata

Clinical Guides in Oncology

SEOM clinical guidelines for the treatment of osteosarcoma in adults-2013

A. Redondo, J. Cruz, A. Lopez-Pousa, F. Barón

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine